We are live on
!
Find out more
KRW
Kaufman Rossin Wealth Portfolio holdings
AUM
$211M
1-Year Est. Return
35.68%
This Fund
S&P 500
This Quarter
Est. Return
+15.14%
1 Year Est. Return
+35.68%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$211M
AUM Growth
+$36.6M
(+21%)
Cap. Flow
+$14.3M
Cap. Flow
% of AUM
6.77%
Top 10 Holdings %
Top 10 Hldgs %
70.09%
Holding
116
New
18
Increased
38
Reduced
39
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EA Bridgeway Omni Small-Cap Value ETF
BSVO
|
+$3.64M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$3.6M |
| 3 |
Avantis International Small Cap Value ETF
AVDV
|
+$1.77M |
| 4 |
Dimensional US High Profitability ETF
DUHP
|
+$1.64M |
| 5 |
Dimensional International High Profitability ETF
DIHP
|
+$1.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$896K |
| 2 |
Arista Networks
ANET
|
+$576K |
| 3 |
GE Aerospace
GE
|
+$442K |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$432K |
| 5 |
NVIDIA
NVDA
|
+$379K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.58% |
| 2 | Industrials | 3.07% |
| 3 | Healthcare | 2.32% |
| 4 | Consumer Discretionary | 2.06% |
| 5 | Communication Services | 0.88% |
Similar funds
RF
CI
SGWM
UI
PC
AWP
UAH
MWM
Kaufman Rossin Wealth's Q2 2026 Portfolio in Review
As of Q2 2026, Kaufman Rossin Wealth held 116 positions worth $211M, up 21% from $174M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Kaufman Rossin Wealth deployed $14.3M of net new capital in Q2 2026, opening 18 new positions and adding to 38 existing holdings. Its largest new stake was Oracle: 1,464 shares worth $211K.
By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 7.4% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Intel, an estimated $896K trimmed.
- Kaufman Rossin Wealth's largest Q2 2026 buy was Oracle: 1,464 shares worth $211K.
- Kaufman Rossin Wealth added most to EA Bridgeway Omni Small-Cap Value ETF in Q2 2026, an estimated $3.64M increase.
- Kaufman Rossin Wealth's biggest Q2 2026 reduction was Intel, cutting an estimated $896K.
- Kaufman Rossin Wealth fully exited Regeneron Pharmaceuticals in Q2 2026, selling an estimated $432K.
- Kaufman Rossin Wealth's ten largest holdings make up 70% of its $211M portfolio in Q2 2026.
- Kaufman Rossin Wealth opened 18 new positions and closed 4 in Q2 2026.
- Kaufman Rossin Wealth's portfolio value rose 21% quarter-over-quarter to $211M.
Based on Kaufman Rossin Wealth's 13F filing for Q2 2026, filed 16 Jul 2026.